VEGFA and retinopathy of prematurity: Approximately one-third of infants with ROP (979, 35.2%) received ROP treatment, including laser photocoagulation alone (572, 58.4%), anti-VEGF therapy alone (200, 20.4%), or both laser photocoagulation and anti-VEGF therapy (173, 17.7%).